These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 13848669)

  • 1. [Bacteriological action of 1-(p-[N,N-dimethylaminolphenyl)-3-(p-n-butoxyphenyl)-2-thiorea on leprosy of the lepromatous type and on leprosy of the sulfone-resistant dimorphic type].
    MONTESTRUC E; BENOIST J
    Bull Soc Pathol Exot Filiales; 1960; 53():13-6. PubMed ID: 13848669
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bacteriological action of Ciba-1906 (1-(p-dimethylaminophenyl)-3-(p-butoxyphenyl)-2-thiourea) in lepers of the lepromatous and sulfone-resistant dimorphous type].
    MONTESTRUC E; BENOIST J
    Arch Inst Pasteur Martinique; 1960; 13():17-9. PubMed ID: 13772179
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical evaluation studies in lepromatous leprosy. 4. 4, Butoxy-4'dimethylaminodiphenyl thiourea (DPT), amodiaquin, and 4-4'diaminodiphenyl sulfone (DDS) 2.5 mgm, and 4 mgm. per kg. of body weight.
    DOULL JA; RODRIGUEZ JN; TOLENTINO JG; FERNANDEZ JV; GUINTO RS; RIVERA JN; MABALAY MC
    Int J Lepr; 1961; 29():291-317. PubMed ID: 13887566
    [No Abstract]   [Full Text] [Related]  

  • 4. [Histological and bacteriological changes in lepromatous leprosy after treatment with diamino-diphenyl-sulfone (sulfone mère)].
    NICOLAU SG; VULCAN P
    Arch Klin Exp Dermatol; 1958; 207(5):486-98. PubMed ID: 13595786
    [No Abstract]   [Full Text] [Related]  

  • 5. The absorption, metabolism and excretion of 1-(p-dimethylaminophenyl)-3-(p-butoxyphenyl)-2-thiourea in man. 2. A study using 35S-labelled drug.
    ELLARD GA; NAYLOR RF
    Lepr Rev; 1961 Oct; 32():249-58. PubMed ID: 13889888
    [No Abstract]   [Full Text] [Related]  

  • 6. The absorption, metabolism and excretion of 1-(p-dimethylaminophenyl)-3-(p-butoxyphenyl)-2-thiourea in man. 1. A study using colorimetric methods.
    ELLARD GA
    Lepr Rev; 1961 Oct; 32():233-48. PubMed ID: 13889889
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diamino-diphenyl-sulfone, dihydrostreptomycin and p-aminosalicylic acid in the treatment of lepromatous leprosy].
    GONZALEZ OCHOA A; MARTINEZ BAEZ M; LAVALLE AGUILAR P; CASTRO ESTRADA S
    Bol Oficina Sanit Panam; 1952 Oct; 33(4):306-29. PubMed ID: 12977879
    [No Abstract]   [Full Text] [Related]  

  • 8. Bacteriological results of treatment of lepromatous cases with diaminodiphenyl sulfone by mouth for periods up to five years.
    ROY AT
    Int J Lepr; 1956; 24(1):45-50. PubMed ID: 13366482
    [No Abstract]   [Full Text] [Related]  

  • 9. [The 4:4 '-diamino diphenyl sulfone in the treatment of lepromatous leprosy].
    DUARTE LG; DE MELLO PH
    Rev Bras Leprol; 1953 Sep; 21(3):207-20. PubMed ID: 13167563
    [No Abstract]   [Full Text] [Related]  

  • 10. Relapses after sulfone therapy in leprosy of the lepromatous type.
    RODRIGUEZ JN
    Int J Lepr; 1959; 26(4):305-12. PubMed ID: 13672660
    [No Abstract]   [Full Text] [Related]  

  • 11. Progress with new anti-leprosy drugs.
    DAVEY TF
    Int J Lepr; 1959; 26(4):299-304. PubMed ID: 13672659
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of diaminodiphenylsulfone and thiosemicarbazone in the treatment of lepromatous leprosy; clinical and bacteriological evaluation in sixty hospitalized patients.
    SAGHER F; BRAND N
    Int J Lepr; 1953; 21(2):161-7. PubMed ID: 13096167
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical evaluation studies in lepromatous leprosy; third series: nicotinamide, and BCG vaccination as supplements to diaminodiphenyl sulfone (DDS).
    DOULL JA; RODRIGUEZ JN; DAVISON AR; TOLENTINO JG; FERNANDEZ JV
    Int J Lepr; 1958; 26(3):219-35. PubMed ID: 13640759
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sulfone therapy in lepromatous children at Colônia Santa Isabel, Brazil].
    ORSINI O; TAVARES I
    Arq Min Leprol; 1951 Jan; 11(1):16-33. PubMed ID: 14869252
    [No Abstract]   [Full Text] [Related]  

  • 15. [Severe relapse of a lepromatous leper treated for six years by the sulfone J-51].
    CHAUSSINAND R; BOURCART N
    Presse Med (1893); 1959 Aug; 67():1534. PubMed ID: 13809492
    [No Abstract]   [Full Text] [Related]  

  • 16. ICONOGRAPHIA DERMATOLOGICA. 11. SUBCUTANEOUS "BORDERLINE NODULES" IN LEPROMATOUS LEPROSY.
    OGAWA J; KANETSUNA F; TODA E; NISHIURA M
    Hifuka Kiyo; 1963 Jan; 58():1-2. PubMed ID: 14045185
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sulfone therapy of leprosy; fate of oral succinyldiaminodiphenylsulfone, monosubstituted sulfone, in the organism; mode of action].
    FLOCH H; LECUILLER A; DESTOMBES P
    Bull Soc Pathol Exot Filiales; 1951; 44(7-8):410-3. PubMed ID: 14905185
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sulfone therapy of leprosy; fate of phenylpropyldiaminodiphenylsulfone (disubstituted sulfone) administered orally; mode of action].
    FLOCH H; LECUILLER A; SUREAU P
    Bull Soc Pathol Exot Filiales; 1952; 45(5):583-7. PubMed ID: 13032737
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sulfone therapy of leprosy; fate of aminohydroxyethylaminodiphenylsulfone (1087 MM), monosubstituted sulfone administered orally; method of action].
    FLOCH H; LECUILLER A
    Bull Soc Pathol Exot Filiales; 1951; 44(9-10):527-30. PubMed ID: 14905210
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of lepromatous leprosy with combined sulfone-streptomycin-hydrazide of isonicotinic acid].
    ORSINI O
    Arq Min Leprol; 1957 Jul; 17(3):291-4. PubMed ID: 13522478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.